Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C E Fletcher

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Journal of Nursing Administration|January 7, 1998
Failure mode and effects analysis. An interdisciplinary way to analyze and reduce medication errorsC E Fletcher
Journal of Addictive Diseases|January 5, 2002
Michigan's unique approach to treating impaired health care professionalsC E Fletcher
The Journal of Nursing Administration|June 22, 2001
Hospital RNs' job satisfactions and dissatisfactionsC E Fletcher
The Journal of Endocrinology|January 9, 2023
Apoptosis-modulatory miR-361-3p as a novel treatment target in endocrine-responsive and endocrine-resistant breast cancerJ N Zamarbide Losada, E Sulpice, S Combe, et al.
Molecular Cancer|March 23, 2022
A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancerC E Fletcher, L Deng, F Orafidiya, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Journal of Nursing Administration|January 7, 1998
Failure mode and effects analysis. An interdisciplinary way to analyze and reduce medication errorsC E Fletcher
Journal of Addictive Diseases|January 5, 2002
Michigan's unique approach to treating impaired health care professionalsC E Fletcher
The Journal of Nursing Administration|June 22, 2001
Hospital RNs' job satisfactions and dissatisfactionsC E Fletcher
The Journal of Endocrinology|January 9, 2023
Apoptosis-modulatory miR-361-3p as a novel treatment target in endocrine-responsive and endocrine-resistant breast cancerJ N Zamarbide Losada, E Sulpice, S Combe, et al.
Molecular Cancer|March 23, 2022
A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancerC E Fletcher, L Deng, F Orafidiya, et al.
Pageof 1